Fortrea Holdings (FTRE) Other Non Operating Income (2022 - 2026)
Fortrea Holdings (FTRE) posted Other Non Operating Income of $500000.0 for Q1 2026, down 58.33% on a QoQ basis from $1.2 million in Q4 2025.
Fortrea Holdings (FTRE) Other Non Operating Income (2022 - 2026) Analysis & Trends
Fortrea Holdings' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $500000.0 for Q1 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to $500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.1 million (up 52.19% YoY) and the FY2025 annual result came in at -$26.9 million, down 153.77% from the prior year.
- Other Non Operating Income was $500000.0 for Q1 2026 at Fortrea Holdings, down from $1.2 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $5.1 million in Q3 2025 and bottomed at -$25.7 million in Q4 2024.
- A 5-year average of -$3.8 million and a median of $500000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income tumbled 1813.33% — and 2025, when it surged 2650.0%.
- Fortrea Holdings' Other Non Operating Income stood at -$23.1 million in 2022, then soared by 106.49% to $1.5 million in 2023, then tumbled by 1813.33% to -$25.7 million in 2024, then surged by 104.67% to $1.2 million in 2025, then sank by 58.33% to $500000.0 in 2026.
- Business Quant data shows FTRE's Other Non Operating Income at $500000.0 in Q1 2026, $1.2 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | -19.90 Mn |
| Dec 31, 2024 | -25.70 Mn |
| Sep 30, 2024 | -200,000.00 |
| Jun 30, 2024 | -1.50 Mn |
| Mar 31, 2024 | -5.30 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | -23.10 Mn |
| Sep 30, 2022 | 4.80 Mn |
| Jun 30, 2022 | 400,000.00 |